Table 2.
Multivariate Cox proportional hazards models for risk of recurrence, distant metastasis and overall survival for copy number imbalance in LRIG1
| Patient or tumor characteristic | Any Recurrence | Distant Metastasis | Overall Survival | |||
|---|---|---|---|---|---|---|
| HR (95% CI) | p value | HR (95% CI) | p value | HR (95% CI) | p value | |
| Age, diagnosis (y) | ||||||
| < 50 | Reference | Reference | Reference | |||
| ≥ 50 | 1.60 (1.24–2.07) | 0.0003 | 1.58 (1.19–2.09) | 0.002 | 0.69 (0.55–0.87) | 0.002 |
| Tumor size (cm) | ||||||
| < 2 | Reference | Reference | Reference | |||
| ≥ 2 | 1.71 (1.33–2.22) | < 0.0001 | 1.99 (1.50–2.64) | < 0.0001 | 1.59 (1.28–1.98) | < 0.0001 |
| Lymph node | ||||||
| Negative | Reference | Reference | Reference | |||
| Positive | 1.62 (1.26–2.10) | 0.0002 | 1.85 (1.39–2.46) | < 0.0001 | 1.39 (1.12–1.74) | 0.003 |
| LRIG1 | ||||||
| Copy normal | Reference | Reference | Reference | |||
| Loss | 1.91 (1.33–2.74) | 0.0004 | 2.10 (1.43–3.09) | < 0.0001 | 1.55 (1.11–2.16) | 0.009 |
| Gain | 0.87 (0.43–1.78) | 0.71 | 0.94 (0.44–2.01) | 0.87 | 0.97 (0.56–1.71) | 0.93 |
Abbreviations: HR, hazard ratio; CI, confidence interval
Note: The clinical covariates shown above were chosen using a stepwise selection procedure to minimize Akaike Information Criterion.